Clincosm LogoSign in Get a demo

moderate to severe asthma

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Moderate to Severe Asthma Trial (povorcitinib, , ICS-LABA)

Not yet recruiting
  • Moderate to Severe Asthma
  • (no location specified)
May 9, 2023

Moderate to Severe Asthma Trial in Shanghai (CM326, Placebo)

Not yet recruiting
  • Moderate to Severe Asthma
  • Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Mar 15, 2023

Moderate to Severe Asthma Trial in Beijing (CM310, Placebo)

Not yet recruiting
  • Moderate to Severe Asthma
  • Beijing, Beijin, China
    China-Japan Friendship Hospital
Feb 27, 2023

Moderate to Severe Asthma Trial in United States (Tezepelumab, Placebo)

Completed
  • Moderate to Severe Asthma
  • Bakersfield, California
  • +14 more
Sep 28, 2022

Moderate to Severe Asthma Trial in Chapel Hill (3% Hypertonic Saline, 7% Hypertonic Saline)

Recruiting
  • Moderate to Severe Asthma
  • 3% Hypertonic Saline
  • 7% Hypertonic Saline
  • Chapel Hill, North Carolina
    Center for Environmental Medicine, Asthma and Lung Biology
Jan 4, 2022

Moderate to Severe Asthma Trial in Nedlands (KBL693)

Completed
  • Moderate to Severe Asthma
  • Nedlands, Western Australia, Australia
    Linear Clinical Research
Feb 18, 2021